These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38983799)

  • 21. Severe ovarian hyperstimulation syndrome modifies early maternal serum beta-human chorionic gonadotropin kinetics, but obstetrical and neonatal outcomes are not impacted.
    Choux C; Barberet J; Ginod P; Cottenet J; Bruno C; Benzénine E; Sagot P; Fauque P
    Fertil Steril; 2017 Oct; 108(4):650-658.e2. PubMed ID: 28911926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patients with IVF complicated by moderate-to-critical OHSS experience increased thrombosis, GDM and neonatal NICU admission but slightly shorter gestation compared with matched IVF counterparts: A retrospective Chinese cohort study.
    Hu L; Xie R; Wang M; Sun Y
    Reprod Biol Endocrinol; 2021 Jan; 19(1):8. PubMed ID: 33441149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid Metabolic Disorders and Ovarian Hyperstimulation Syndrome: A Retrospective Analysis.
    Liu F; Jiang Q; Sun X; Huang Y; Zhang Z; Han T; Shi Y
    Front Physiol; 2020; 11():491892. PubMed ID: 33329009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count.
    Ho VNA; Braam SC; Pham TD; Mol BW; Vuong LN
    Hum Reprod; 2019 Jun; 34(6):1055-1064. PubMed ID: 31111879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal outcomes of singleton live births after late moderate-to-severe ovarian hyperstimulation syndrome: A propensity score-matched study.
    Ran S; Zu R; Wu H; Zheng W; Yang C; Yang S; Ren B; Zhang W; Du J; Guan Y
    Front Endocrinol (Lausanne); 2022; 13():1063066. PubMed ID: 36531504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoing in vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study.
    Kılıç N; Özdemir Ö; Başar HC; Demircan F; Ekmez F; Yücel O
    Avicenna J Med; 2015; 5(4):123-7. PubMed ID: 26629467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy outcomes after assisted human reproduction.
    Okun N; Sierra S; ;
    J Obstet Gynaecol Can; 2014 Jan; 36(1):64-83. PubMed ID: 24444289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Higher Blood Pressure in 3 to 6 Years Old Singleton Born From OHSS Patients Undergone With Fresh IVF/ICSI.
    Zhu Y; Fu Y; Tang M; Yan H; Zhang F; Hu X; Feng G; Sun Y; Xing L
    Front Endocrinol (Lausanne); 2022; 13():817555. PubMed ID: 35865308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cabergoline for preventing ovarian hyperstimulation syndrome.
    Tang H; Hunter T; Hu Y; Zhai SD; Sheng X; Hart RJ
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008605. PubMed ID: 22336848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Embryo freezing for preventing Ovarian Hyperstimulation Syndrome.
    D'Angelo A; Amso N
    Cochrane Database Syst Rev; 2002; (2):CD002806. PubMed ID: 12076453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy Outcomes of In Vitro Fertilization with or without Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study in Chinese Patients.
    Jiang X; Deng CY; Sun ZY; Chen WL; Wang HB; Zhou YZ; Jin L
    Chin Med J (Engl); 2015 Dec; 128(23):3167-72. PubMed ID: 26612291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association between Ovarian Hyperstimulation Syndrome and Pregnancy Complications following Fertility Treatments.
    Vainer-Rotbart S; Sheiner E; Harlev A; Bar G; Levy A
    Am J Perinatol; 2023 Jul; 40(10):1088-1095. PubMed ID: 34327685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
    Kwan I; Bhattacharya S; McNeil A; van Rumste MM
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005289. PubMed ID: 18425917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF/ICSI for high responders: a randomized controlled trial.
    Santos-Ribeiro S; Mackens S; Popovic-Todorovic B; Racca A; Polyzos NP; Van Landuyt L; Drakopoulos P; de Vos M; Tournaye H; Blockeel C
    Hum Reprod; 2020 Dec; 35(12):2808-2818. PubMed ID: 32964939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hyperstimulation syndrome.
    Ragni G; Vegetti W; Riccaboni A; Engl B; Brigante C; Crosignani PG
    Hum Reprod; 2005 Sep; 20(9):2421-5. PubMed ID: 15890731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GnRH antagonist rescue of a short-protocol IVF/ICSI cycle and GnRH agonist triggering to prevent ovarian hyperstimulation syndrome: two case reports.
    Bakas P; Boutas I; Giner M; Panagopoulos P; Aravantinos L
    Clin Exp Obstet Gynecol; 2017; 44(2):279-282. PubMed ID: 29746040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe ovarian hyperstimulation syndrome in a 42-year-old woman with successful pregnancy after intracytoplasmic sperm injection embryo transfer.
    Shibahara H; Shimada K; Morimatsu Y; Kikuchi K; Hirano Y; Suzuki T; Takamizawa S; Suzuki M
    Reprod Med Biol; 2005 Dec; 4(4):265-269. PubMed ID: 29699230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes.
    Roque M; Haahr T; Geber S; Esteves SC; Humaidan P
    Hum Reprod Update; 2019 Jan; 25(1):2-14. PubMed ID: 30388233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.